Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Darbepoetin Alfa in Patients With Chronic Lymphocytic Leukemia and Comorbidity

NCT00281892 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT00281892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00281892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Darbepoetin Alfa in Patients With Chronic Lymphocytic Leukemia and Comorbidity
Lead sponsor
German CLL Study Group
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2004
Completion date
October 31, 2010
Enrollment
97 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chronic lymphocytic leukemia